We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+17.92%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$1.8B
AUM Growth
+$309M
Cap. Flow
+$93M
Cap. Flow %
5.17%
Top 10 Hldgs %
21.26%
Holding
2,654
New
182
Increased
672
Reduced
615
Closed
94

Sector Composition

Rank Sector Weight
1 Technology 7.59%
2 Healthcare 5.21%
3 Financials 5.09%
4 Consumer Discretionary 4.47%
5 Energy 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGL icon
1076
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.82B
$69K ﹤0.01%
1,368
+55
+4% +$2.75K
RVT icon
1077
Royce Value Trust
RVT
$2.3B
$69K ﹤0.01%
5,782
-313
-5% -$3.59K
AUY
1078
DELISTED
Yamana Gold, Inc.
AUY
$69K ﹤0.01%
13,337
+5
+0% +$24
JTD
1079
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
$69K ﹤0.01%
5,530
STL
1080
DELISTED
Sterling Bancorp
STL
$69K ﹤0.01%
6,601
-13
-0.2% -$149
BBHY icon
1081
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$618M
$68K ﹤0.01%
1,401
-504
-26% -$24K
ETSY icon
1082
Etsy
ETSY
$7.85B
$68K ﹤0.01%
665
HQH
1083
abrdn Healthcare Investors
HQH
$1.32B
$68K ﹤0.01%
3,278
+48
+1% +$978
MDXG icon
1084
MiMedx Group
MDXG
$633M
$68K ﹤0.01%
12,665
-500
-4% -$2.69K
RSPM icon
1085
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$194M
$68K ﹤0.01%
3,500
ZION icon
1086
Zions Bancorporation
ZION
$10.3B
$68K ﹤0.01%
2,119
+2
+0.1% +$63
TVRD
1087
Tvardi Therapeutics
TVRD
$23.4M
$68K ﹤0.01%
112
-7
-6% -$3.87K
AVAV icon
1088
AeroVironment
AVAV
$9.45B
$67K ﹤0.01%
870
CVNA icon
1089
Carvana
CVNA
$77.9B
$67K ﹤0.01%
2,870
DEA
1090
Easterly Government Properties
DEA
$1.18B
$67K ﹤0.01%
1,192
+50
+4% +$3.17K
ESPR
1091
DELISTED
Esperion Therapeutics
ESPR
$67K ﹤0.01%
1,470
-150
-9% -$6.28K
FREL icon
1092
Fidelity MSCI Real Estate Index ETF
FREL
$1.49B
$67K ﹤0.01%
2,984
-217
-7% -$4.89K
GDV icon
1093
Gabelli Dividend & Income Trust
GDV
$2.66B
$67K ﹤0.01%
3,925
-824
-17% -$13.9K
HYD icon
1094
VanEck High Yield Muni ETF
HYD
$4.45B
$67K ﹤0.01%
1,138
+5
+0.4% +$282
NBTB icon
1095
NBT Bancorp
NBTB
$2.74B
$67K ﹤0.01%
2,343
PFIG icon
1096
Invesco Fundamental Investment Grade Corporate Bond ETF
PFIG
$118M
$67K ﹤0.01%
2,500
PLD icon
1097
Prologis
PLD
$133B
$67K ﹤0.01%
749
-233
-24% -$20.8K
RA
1098
Brookfield Real Assets Income Fund
RA
$708M
$67K ﹤0.01%
4,101
ROK icon
1099
Rockwell Automation
ROK
$49B
$67K ﹤0.01%
328
+2
+0.6% +$387
STEW
1100
SRH Total Return Fund
STEW
$1.81B
$67K ﹤0.01%
7,272

Similar funds

Geneos Wealth Management's Q2 2020 Portfolio in Review

As of Q2 2020, Geneos Wealth Management held 2,654 positions worth $1.8B, up 21% from $1.49B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geneos Wealth Management deployed $93M of net new capital in Q2 2020, opening 182 new positions and adding to 672 existing holdings. Its largest new stake was ProShares Ultra Technology: 799,424 shares worth $17.5M.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $39.5M trimmed.

  • Geneos Wealth Management's largest Q2 2020 buy was ProShares Ultra Technology: 799,424 shares worth $17.5M.
  • Geneos Wealth Management added most to iShares Core US Aggregate Bond ETF in Q2 2020, an estimated $21.4M increase.
  • Geneos Wealth Management's biggest Q2 2020 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $39.5M.
  • Geneos Wealth Management fully exited Boingo Wireless, Inc. in Q2 2020, selling an estimated $445K.
  • Geneos Wealth Management's ten largest holdings make up 21% of its $1.8B portfolio in Q2 2020.
  • Geneos Wealth Management opened 182 new positions and closed 94 in Q2 2020.
  • Geneos Wealth Management's portfolio value rose 21% quarter-over-quarter to $1.8B.

Based on Geneos Wealth Management's 13F filing for Q2 2020, filed 7 Sep 2021.